Royalty Pharma plc (FRA:RPD)
Germany · Delayed Price · Currency is EUR 32.38
+0.08 (0.25%)
At close: Dec 19, 2025
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of €14.07 billion as of December 22, 2025. Its market cap has increased by 27.81% in one year.
Market Cap
14.07B
Enterprise Value
23.65B
Revenue
2.00B
Ranking
n/a
PE Ratio
21.59
Stock Price
€32.38
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from 14.00B to 14.07B, an increase of 0.53%. That is a compound annual growth rate of 0.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 14.07B | 28.56% |
| Dec 31, 2024 | 10.95B | -3.17% |
| Dec 29, 2023 | 11.31B | -30.69% |
| Dec 30, 2022 | 16.31B | 8.38% |
| Dec 31, 2021 | 15.05B | -5.23% |
| Dec 31, 2020 | 15.88B | 13.43% |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 130.23B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |